A prospective trial of the effect of adjuvant trastuzumab treatment in patients with small node negative her2+ breast cancer

Trial Profile

A prospective trial of the effect of adjuvant trastuzumab treatment in patients with small node negative her2+ breast cancer

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2014

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 25 Jul 2014 New trial record
    • 03 Jun 2014 Baseline demographics presented at the 50th Annual Meeting of the American Society Clinical Oncology
    • 01 Mar 2013 Status changed to active, no longer recruiting as per 50th Annual Meeting of the American Society Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top